BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37339923)

  • 1. Differential Response of Pelvic Bone Marrow Fluorodeoxyglucose Uptake in Patients Receiving Concurrent Chemoradiotherapy.
    Robinson M; Muirhead R; McGowan DR; Chu KY; Jacobs C; Hawkins MA
    Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):e622-e627. PubMed ID: 37339923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
    Elicin O; Callaway S; Prior JO; Bourhis J; Ozsahin M; Herrera FG
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1099-107. PubMed ID: 25442041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating
    Franco P; Fiandra C; Arcadipane F; Trino E; Giglioli FR; Ragona R; Ricardi U
    BMC Cancer; 2017 Nov; 17(1):710. PubMed ID: 29096619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial.
    Yusufaly T; Miller A; Medina-Palomo A; Williamson CW; Nguyen H; Lowenstein J; Leath CA; Xiao Y; Moore KL; Moxley KM; Chevere-Mourino CM; Eng TY; Zaid T; Mell LK
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1240-1247. PubMed ID: 32629079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
    Rose BS; Liang Y; Lau SK; Jensen LG; Yashar CM; Hoh CK; Mell LK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1185-91. PubMed ID: 22270171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation.
    Rose BS; Jee KW; Niemierko A; Murphy JE; Blaszkowsky LS; Allen JN; Lee LK; Wang Y; Drapek LC; Hong TS; Wo JY
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):747-54. PubMed ID: 26972647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer.
    Robinson M; Muirhead R; Jacobs C; Cooke R; Chu KY; Van den Heuvel F; Ng S; Virdee P; Strauss V; Hawkins M
    Radiother Oncol; 2020 Feb; 143():19-23. PubMed ID: 31506182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies.
    Liang Y; Bydder M; Yashar CM; Rose BS; Cornell M; Hoh CK; Lawson JD; Einck J; Saenz C; Fanta P; Mundt AJ; Bydder GM; Mell LK
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):406-14. PubMed ID: 22687195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of
    Lee JW; Seo KH; Kim ES; Lee SM
    Eur Radiol; 2017 May; 27(5):1912-1921. PubMed ID: 27590191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer.
    Li N; Noticewala SS; Williamson CW; Shen H; Sirak I; Tarnawski R; Mahantshetty U; Hoh CK; Moore KL; Mell LK
    Radiother Oncol; 2017 May; 123(2):325-330. PubMed ID: 28528206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients.
    McGuire SM; Bhatia SK; Sun W; Jacobson GM; Menda Y; Ponto LL; Smith BJ; Gross BA; Bayouth JE; Sunderland JJ; Graham MM; Buatti JM
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):228-39. PubMed ID: 27319286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
    Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
    J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.
    Noticewala SS; Li N; Williamson CW; Hoh CK; Shen H; McHale MT; Saenz CC; Einck J; Plaxe S; Vaida F; Yashar CM; Mell LK
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):797-805. PubMed ID: 28244416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Are Associated with Prognosis.
    Carpenter DJ; Jacobs CD; Wong TZ; Craciunescu O; Chino JP
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):356-366. PubMed ID: 31254659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-automated histogram analysis of normal bone marrow using
    Satoh Y; Funayama S; Onishi H; Kirito K
    BMC Med Imaging; 2022 Feb; 22(1):31. PubMed ID: 35197004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival.
    Everitt S; Ball D; Hicks RJ; Callahan J; Plumridge N; Trinh J; Herschtal A; Kron T; Mac Manus M
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):947-955. PubMed ID: 29063854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated detection, delineation and quantification of whole-body bone metastasis using FDG-PET/CT images.
    Nigam R; Field M; Harris G; Barton M; Carolan M; Metcalfe P; Holloway L
    Phys Eng Sci Med; 2023 Jun; 46(2):851-863. PubMed ID: 37126152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.